3rd Circ. Told Medicare Drug Price Talks Not Voluntary

By George Woolston · October 30, 2024, 7:17 PM EDT

Three pharmaceutical companies told the Third Circuit on Wednesday the Medicare drug price negotiation program is anything but voluntary, arguing the appeals court should revive their challenges to the program because...

To view the full article, register now.

Case Information

Case Title

AstraZeneca Pharmaceuticals LP, et al v. Secretary United States Department of Health and H, et al

Case Number

24-1819

Court

Appellate - 3rd Circuit

Nature of Suit

2899 APA Review/Appeal

Date Filed

May 02, 2024


Case Title

Bristol Myers Squibb Co v. Secretary United States Department of HHS, et al

Case Number

24-1820

Court

Appellate - 3rd Circuit

Nature of Suit

2440 Other Civil Rights

Date Filed

May 06, 2024


Case Title

Janssen Pharmaceuticals Inc v. Secretary United States Department of HHS, et al

Case Number

24-1821

Court

Appellate - 3rd Circuit

Nature of Suit

2440 Other Civil Rights

Date Filed

May 06, 2024